GlassScriptPhysician profile
Scott Michael Reis
NPI 1699092965
$2,974.85
in general payments reported to CMS, 2019-2025
12 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2020: $17.94 · 2021: $345 · 2022: $742 · 2023: $231 · 2024: $781 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $602.53 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $583.85 | 2019-2021 | |
| Davol INC. | $548.63 | 2022-2024 | Phasix Mesh |
| Mentor Worldwide LLC | $519.66 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $277.55 | 2025 | |
| Tela Bio, INC. | $166.21 | 2024 | Ovitex 2s |
| Allergan, INC. | $109.51 | 2020-2022 | |
| Rti Surgical, INC | $67.29 | 2022 | |
| Becton, Dickinson and Company | $39.82 | 2024 | Arista Ah Flexitip |
| Sientra, INC. | $26.06 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.92 | 2019 | |
| Integra Lifesciences Corporation | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Reis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.